Shopping, sword-fighting and silliness: Meet the first-ever WIN Reactor graduates

spree.jpg.jpg

From a retro-futuristic driving game to a healthy shopping and eating app, more than six months of stealth startup work going on at the Washington Interactive Network (WIN) accelerator was shown off at a demo day on Thursday afternoon. It’s been nearly two years since WIN was awarded a $1.2 million grant for what’s now called the WIN Reactor, also known… Read More…

This startup hacks the brain to help make you a better athlete

ikkossmall

For a golfer trying to perfect his or her swing, there are several ways to be like Tiger Woods: You can hire a coach, enroll in a school, buy books or watch videos, just to name a few. What I did the other day was a little different. It required no reading material and no driving… Read More…

Startup pitch contest: Tell us your awesome startup idea and the experts will weigh in

Photo via RootStartup

We’re back for another installment of the Startup Pitch sessions in which entrepreneurs reveal their business ideas (in two sentences or less), and the experts weigh in with advice and feedback. At stake for the winning entrepreneur is a full scholarship to the upcoming 15-week Founder Institute technology accelerator, with the Seattle classes beginning April 9th…. Read More…

After spurning acquisition offer, Seattle’s Freak’n Genius raises $525,000 angel round

freakngenius1-demoday_03

Kyle Kesterson’s new animation startup, Freak’n Genius, has raised $525,000 in fresh funding from more than a dozen angel investors that include Zapd founder Kelly Smith; Jumala founder Virl Hill; Wilson Sonsini Goodrich & Rosati; Chris Hurley; Ty Alevizos and others. Kesterson tells GeekWire that the company hit its original $450,000 funding goal within two weeks of… Read More…

Theraclone Sciences raises $10M

theraclone11

Theraclone Sciences, a Seattle biotechnology company that’s developing a method to rapidly identify disease-fighting antivbodies, has attracted $10.6 million. Investors in the deal include ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, Amgen Ventures and Zenyaku Kogyo “The anticipated near-term initiation of Theraclone’s first clinical trial and our discovery collaboration with Pfizer earlier… Read More…